Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.55 $6.55 Wednesday, 17th Aug 2022 NK stock ended at $6.55. During the day the stock fluctuated 0% from a day low at $6.55 to a day high of $6.55.
90 days $6.55 $6.55
52 weeks $4.81 $12.34

Historical NantKwest prices

Date Open High Low Close Volume
Jan 29, 2016 $10.27 $11.03 $10.00 $10.30 499 800
Jan 28, 2016 $11.11 $11.16 $10.24 $10.30 408 000
Jan 27, 2016 $12.02 $12.04 $10.75 $10.79 511 900
Jan 26, 2016 $12.34 $12.34 $11.01 $11.99 450 800
Jan 25, 2016 $12.67 $13.31 $12.17 $12.24 607 400
Jan 22, 2016 $12.75 $12.94 $12.21 $12.68 282 200
Jan 21, 2016 $12.59 $13.09 $12.00 $12.37 343 300
Jan 20, 2016 $11.64 $12.71 $10.75 $12.48 718 700
Jan 19, 2016 $12.67 $12.77 $11.33 $11.63 461 200
Jan 15, 2016 $12.10 $12.90 $11.60 $12.45 426 400
Jan 14, 2016 $11.95 $13.16 $11.12 $12.91 505 600
Jan 13, 2016 $13.89 $14.23 $11.83 $11.91 499 300
Jan 12, 2016 $13.67 $14.35 $13.14 $13.76 405 900
Jan 11, 2016 $14.50 $14.50 $12.35 $13.54 865 400
Jan 08, 2016 $13.17 $13.92 $13.00 $13.78 611 900
Jan 07, 2016 $14.75 $14.75 $12.88 $12.96 569 600
Jan 06, 2016 $15.40 $15.49 $14.72 $15.04 507 400
Jan 05, 2016 $15.82 $16.25 $15.60 $15.63 297 500
Click to get the best stock tips daily for free!

About NantKwest

NantKwest NantKwest, Inc., a biotechnology company, engages in developing immunotherapeutic agents for various clinical conditions in the United States. The company’s product candidates include activated natural killer candidates for the treatment of virally-induced cancers, such as human papilloma virus induced cervical, and head and neck cancers; ebola; and serious viral, fungal, and bacterial infections, as well as that is in Phase II clinical trials f... NK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT